$HPNN NEWS OUT !!!
Hop-on Subsidiary Re-Medical Seeks Licensing of Cannabis Transdermal Delivery Innovations
February 28, 2017 13:20 ET
TEMECULA, CA--(Marketwired - Feb 28, 2017) - Hop-on, Inc. (OTC PINK: HPNN) announced today its subsidiary, Re-Medical, Inc., is setting up distribution of cannabis transdermal patches in legal jurisdictions.
Re-Medical is actively pursuing opportunities for production and distribution of the Company's various innovative products for the transdermal delivery of standardized cannabinoid formulations. Partnerships, technology licensing agreements, and distribution contracts are being offered to locally authorized marijuana cultivators, producers of infused products, and medical marijuana dispensaries in California, Colorado, Washington, Nevada, and other self-regulated markets in the United States.
Re-Medical's mission is to provide solutions for patients desiring to use cannabis as a nutraceutical alternative to traditional or prescription medications.
Re-Medical is a Hop-on company focused on alternative ways to deliver vitamins, supplements and other healthful products such as cannabis, utilizing transdermal patches and other novel technologies. The company has developed and isolated the benefits of cannabis and other vital plant extracts for best patient care. There are an estimated 80+ cannabinoids found in cannabis, each providing distinctive neuropathic effects. The company is currently applying for patents regarding the delivery of cannabis via transdermal patches. Re-Medical patches offer cost effective, accurate and clean delivery of these unique compounds.
